Recent years, it has been believed that insulin resistance (IR) is the independent
risk factor of dyslipidemia, systemic inflammation, oxidative stress. Nowadays in
different sources we can find quite contradictory facts about the role of polymorphism
insulin receptor substrate-1 (IRS-1) in the development of IR and its consequences.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
EAS-0908
Identification
Copyright
© 2015 Published by Elsevier Inc.
